Skip to main content
Log in

Age-related behavioural, neurochemical and radioligand binding changes in the central 5-HT system of Sprague-Dawley rats

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Mature (3–4 months) and aged (18–19 months) Sprague-Dawley (SD) rats were treated with 5-HT receptor agonists and drug-induced behaviours monitored. The 5-HT2/1C agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), induced wet dog shakes and back muscle contractions which were significantly increased in aged, compared to mature, rats, suggesting an age-related enhancement of 5-HT2 receptor function. In contrast, the selective 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) induced forepaw treading, flat body posture, hypothermia and hyperactivity which were not significantly different in aged compared to mature rats. Levels of 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) in the hippocampus and frontal cortex were measured using high performance liquid chromatography with electrochemical detection. There were no age-related changes in hippocampal 5-HT or 5-HIAA. However both 5-HT and 5-HIAA were increased in the frontal cortex of aged SD rats. 8-OH-DPAT reduced 5-HIAA in both regions examined in mature rats, an effect which was attenuated in the aged rats, suggesting an age-related reduction in presynaptic 5-HT1A receptor function. DOI did not induce any changes in 5-HT or 5-HIAA in either of the regions examined. Radioligand binding studies with [3H] ketanserin showed there to be no significant age-related changes in cortical 5-HT2 receptor density or affinity. In the samples taken from mature rats GTP shifted the competition curve to DOI and reduced the proportion of high affinity agonist binding sites; this effect was not observed in the aged samples, suggesting that there may be age-related changes in G-protein-mediated receptor-effector coupling mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Allen SJ, Benton JS, Goodhart MJ, Haan EA, Sims NR, Smith CCT, Spillane JA, Bowen DM, Davison AN (1983) Biochemical evidence of selective nerve cell changes in the normal ageing human and rat brain. J Neurochem 41:256–265

    Google Scholar 

  • Altman HJ, Normile HJ (1988) what is the nature of the role of the serotonergic nervous system in learning and memory: prospects for development of an effective treatment strategy for senile dementia. Neurobiol Aging 9:627–638

    Google Scholar 

  • Arai H, Kosaka K, Lizuka T (1984). Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. J Neurochem 43:388–393

    Google Scholar 

  • Barnes CA, Forster MJ, Fleshner M, Ahanotu EN, Laudenslager ML, Mazzeo RS, Maier SF, Lal H (1991) Exercise does not modify spatial memory, brain autoimmunity, or antibody response in aged F-344 rats. Neurobiol Aging 12:47–53

    Google Scholar 

  • Berendsen HHG, Broekkamp CLE (1990) Behavioural evidence for functional interactions between 5-HT receptor subtypes in rats and mice. Br J Pharmacol 101:667–673

    Google Scholar 

  • Bill DJ, Knight M, Forster EA, Fletcher A (1991). Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia. Br J Pharmacol 103:1857–1864

    Google Scholar 

  • Bowen DN, Allen SJ, Benton JS, Goodhart MJ, Hann EA, Palmer AM, Sims NR, Smith CCT, Spillane JA, Esiri MM, Neary D, Snowden JS, Wilcock GK, Davison AN (1983) Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem 41:266–272

    Google Scholar 

  • Bradford MM (1976) A rapid and sensitive method for the measurement of microgram quantities of protein utilising the principle of protein dye binding. Anal Biochem 72:248–254

    Google Scholar 

  • Brunello N, Riva M, Rovescalli AC, Galimberti R, Racagni G (1988) Age-related changes in rat serotonergic and adrenergic systems and in receptor responsiveness to subchronic desipramine treatment. Pharmacol Toxicol 63:150–155

    Google Scholar 

  • Bucht G, Adolfsson R, Gottfries C-G, Roos BE, Winblad B (1981) Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation. J Neural Transm 51:85–203

    Google Scholar 

  • Carlsson A, Gottfries C-G (1986) Neurotransmitter abnormalities in old age dementias. In: Leichner H, Paraschos A (eds). Proceedings of the Vth South-East European Neuropsychiatric Conference, Graz, 1983. University Studio Press, Tessaloniki, Greece, pp 634–645

    Google Scholar 

  • Carlsson A, Adolfsson R, Aquilonius SM, Gottfries C-G, Oreland L, Svennerholm L, Winblad B (1980) Biogenic amines in human brain in normal aging, senile dementia and chronic alcoholism. In: Goldstein M, Calne DB, Lieberman A, Thorner MO (eds). Ergot compounds and brain function: neuroendocrine and neuropsychiatric aspects, Raven, New York, pp 295–304

    Google Scholar 

  • Coppen A (1967) The biochemistry of affective disorders. Br J Psychiatry 133:1237–1258

    Google Scholar 

  • Crespi F, Garratt JC, Sleight AJ, Marsden CA (1990) In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism. Neuroscience 35:139–144

    Google Scholar 

  • Curico CA, Kemper T (1984) Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density. J Neuropathol Exp Neurol 43:359–368

    Google Scholar 

  • Fone KCF, Johnson JV, Bennett GW, Marsden CA (1989) Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats. Br J Pharmacol 96:599–608

    Google Scholar 

  • Godefroy F, Bassant MH, Weil-Fugazza J, Lamour Y (1989) Age-related changes in dopaminergic and serotonergic indices in the rat forebrain. Neurobiol Aging 10:187–190

    Google Scholar 

  • Goodwin, GM, Green AR (1985) A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Br J Pharmacol 84:743–753

    Google Scholar 

  • Gottfries C-G (1988) Alzheimer's disease. A critical review. Comp Gerontol 2:47–62

    Google Scholar 

  • Gottfries C-G (1991) Disturbance of the 5-hydroxytryptamine metabolism in ageing and in Alzheimer's and vascular dementias. In: Sandler M, Coppen A and Harnett S (eds). 5-Hydroxytryptamine in Psychology. Oxford University Press, Oxford, pp 309–323

    Google Scholar 

  • Gottfries C-G, Roos BE, Winblad B (1976) Monoamine and monoamine metabolites in the human brain post mortem in senile dementia. Aktuel Gerontol 6:429–435

    Google Scholar 

  • Gottfries C-G, Adolfsson R, Aquilonius SM, Carlsson A, Eckernas A, Nordberg A, Oreland L, Svennerholm L, Wieberg A, Winblad B (1983) Biochemical changes in dementia disorders of Alzheimer type. Neurobiol Aging 4:261–271

    Google Scholar 

  • Gottfries C-G, Bartfarti T, Carlsson A, Eckernas SA, Svennerholm L (1986) Multiple biochemical deficits in both gray and white matter of Alzheimer brains. Prog in Neuropsychopharmacol Biol Psychiatry 10:405–413

    Google Scholar 

  • Gower AJ, Gobert J (1992) Age-related changes in 5-HT mediated effects in vivo in the rat. J Psychopharmacol 6:128

    Google Scholar 

  • Gozlan H, Daval G, Verge D, Spampinato U, Fattaccini CM, Gallissot MC, El Mestikawy S, Hamon M (1990) Aging associated changes in serotonergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain. Neurobiol Aging 11:437–449

    Google Scholar 

  • Hardy JA, Adolfsson R, Alafuzoff I, Bucht G, Marcusson J, Nyberg P, Perdahl E, Wester P, Winblad B (1985) Transmitter defects in Alzheimer's disease Neurochem Int 17:545–563

    Google Scholar 

  • Hjorth S. Carlsson A, Lindberg P, Sanchez D, Wikstrom H, Arvidsson L-E, Hacksell U, Nilsson JLG (1982) 8-Hydroxy-2-(di-n-propylamino) tetralin, 8-OHDPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity. J Neural Transm 55:169–188

    Google Scholar 

  • Hjorth S, Sharp T (1990) Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies. Life Sci 46:955–963

    Google Scholar 

  • Kahn RS, van Praag HM, Wetzler S, Asnis GY, Barr G (1988) Serotonin and anxiety revisited. Biol. Psychiatry 23:189–208

    Google Scholar 

  • Kennett GA, Curzon G (1988) Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol 94:137–147

    Google Scholar 

  • Lawlor BA, Sunderland T, Mellow AM, Hill JL, Molchan SE, Murphy DL (1989). Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. Arch Gen Psychiatry 46:542–549

    Google Scholar 

  • Leysen JE, Niemegeers CJE, van Neuten JM, Laduron PM (1982). [3H] Ketanserin (R41 468), a selective3H-ligand for serotonin2 receptor binding sites. Mol Pharmacol 21:301–314

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  • Marcinkiewicz M, Verge D, Gozlan H, Pichat L, Hamon M (1984) Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain. Brain Res 291:159–163

    Google Scholar 

  • Marcusson JO, Morgan DG, Winblad B, Finch CE (1984a) Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age. Brain Res 311:51–56

    Google Scholar 

  • Marcusson JO, Oreland L, Winblad B (1984b) Effect of age on human brain serotonin (S-1) sites. J Neurochem 43:1699–1705

    Google Scholar 

  • Marcusson JO, Alafuzoff I, Backstrom IT, Ericson E, Gottfries C-G, Winblad B (1987) 5-Hydroxytryptamine-sensitive3H-imipramine binding of protein nature in the human brain. II. Effect of normal aging and dememtia disorders. Brain Res 425:137–145

    Google Scholar 

  • McEntee WJ, Crook TH (1991) Serotonin, memory and the aging brain. Psychopharmacology 103:143–149

    Google Scholar 

  • Michel T, Hoffman BB, Lefkowitz RJ (1980) Differential regulation of theα 2-adrenergic receptor by Na+ and guanine nucleotides. Nature 228:709–711

    Google Scholar 

  • Middlemiss DN, Palmer AM, Edel N, Bowen DM (1986) Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin in normal and Alzheimer brain. J Neurochem 46:993–996

    Google Scholar 

  • Moretti A, Carfagna N, Trunzo F (1987) Effect of aging on monoamines and their metabolites in the rat brain. Neurochem Res 12:1035–1039

    Google Scholar 

  • Palmer AM, Francis PT, Benton JS, Sims NR, Mann DMA, Neary D, Bowen DM (1987) Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J Neurochem 8:8–15

    Google Scholar 

  • Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205–230

    Google Scholar 

  • Reynolds GP, Arnold L, Rossor MN, Iversen LL, Mountjoy CQ, Roth M (1984) Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type. Neurosci Lett 44:47–51

    Google Scholar 

  • Sharp T, Backus LI, Hjorth S, Bramwell SR, Grahame-Smith DG (1990) Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist. BMY 7378. Eur J Pharmacol 176:331–340

    Google Scholar 

  • Simpkins JW, Mueller GP, Huang HH, Meites J (1977) Evidence for depressed catecholamine and enhanced serotonin metabolism in ageing male rats. Endocrinology 100:1672–1678

    Google Scholar 

  • Timiras PS, Hudson DB, Miller C (1982) Developing and aging brain serotonergic systems. In: Giacobini E, Filogamo G, Giacobini G, Vernadakis A (eds) The aging brain: cellular and molecular mechanisms of aging in the central nervous system. Aging, vol 20. Raven, New York, pp 173–184

    Google Scholar 

  • Tricklebank MD, Forler C, Fozard JR (1985) The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino) tetralin in the rat. Eur J Pharmacol 106:271–282

    Google Scholar 

  • van Kammen DP, Gelernter J (1987) Biochemical instability in schizophrenia II; The serotonin and gabba-aminobutyric acid systems. In: Meltzer HY (ed). Psychopharmacology: the third generation of progress. Raven, New York, pp 753–758

    Google Scholar 

  • Verge D, Daval G, Marcinkiewicz M, Patey A, El Mestikawy S, Gozlan H, Hamon M (1986) Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxy-tryptamine-treated rats. J Neurosci 6:3474–3482

    Google Scholar 

  • Wester P, Hardy JA, Marcusson J, Nybers P, Winblad B (1984) Serotonin concentrations in normal aging human brains: relation to serotonin receptors. Neurobiol Aging 5:199–203

    Google Scholar 

  • Wilner P (1985) Antidepressants and serotonergic neurotransmission: an integrative review. Psychopharmacology 85:387–404

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robson, L., Gower, A.J., Kendall, D.A. et al. Age-related behavioural, neurochemical and radioligand binding changes in the central 5-HT system of Sprague-Dawley rats. Psychopharmacology 113, 274–281 (1993). https://doi.org/10.1007/BF02245710

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245710

Key words

Navigation